Clinical impact of ceftazidime-avibactam for the treatment of carbapenemase-producingEnterobacterales bacteremia in high-risk neutropenic patients Navegación de entradas Bacteremia in cancer patients: Has the COVID-19 pandemic changed the epidemiology? Comparison of iron-depleted (ID) versus cation-adjusted Mueller-Hinton broth (CAMHB)media for cefiderocol susceptibility among carbapenemase-producing Enterobacterales (CPEs)